Aerosolized antibiotics and ventilator-associated tracheobronchitis in the intensive care unit*

Abstract

In critically ill patients with ventilator-associated tracheobronchitis, AA decrease VAP and other signs and symptoms of respiratory infection, facilitate weaning, and reduce bacterial resistance and use of systemic antibiotics.